ABD957 is a potent and selective covalent inhibitor of the ABHD17 family of depalmitoylases, with an IC 50 of 0.21 μM for ABHD17B. ABD957 can block N-Ras signaling and the growth of NRAS-mutant AML cells.
性状
Solid
IC50 & Target[1][2]
IC50: 0.21 μM (ABHD17B)
体外研究(In Vitro)
ABD957 (500 nM; pretreated for 1 h) attenuates N-Ras depalmitoylation in AML cells.ABD957 (0.11 nM-10 μM; 72 h) blocks the signaling and proliferation of NRAS-mutant leukemia cells. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Proliferation Assay
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Remsberg JR, et, al. ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth. Nat Chem Biol. 2021 Aug;17(8):856-864.
溶解度数据
In Vitro: DMSO : 25 mg/mL (39.83 mM; ultrasonic and warming and heat to 60°C)配制储备液